Blinatumomab Consolidation in Real World

Recruiting now

Conditions studied: B-Cell Acute Lymphoblastic Leukaemia

In brief

This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical \& Translational Science Institute.

Key facts

Study ID

NCT07117136

Run by

Medical College of Wisconsin

People needed

200

Starts

2025-08-28

Expected to finish

2029-05-14

Last updated by the study team

2026-07-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 1) aged 18 years or older 2) diagnosed with B-ALL on or after December 1st 2022 3) Not received blinatumomab in an interventional clinical trial setting 4) Willing and able to give informed consent (or retrospective data for deceased patients

You may not qualify if…

• N/A

Where it is running

• Mayo Clinic Cancer Center — Jacksonville, Florida, United States (enrolling)
• University of Pennsylvania — Philadelphia, Pennsylvania, United States (enrolling)
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.